Andrea Easom, MA, MNSC, APRN, BC, CNN
This satellite symposium
is sponsored by an unrestricted educational grant
from Watson Pharma, Inc. This activity
has been planned and produced in accordance with
CE guidelines and policies. From a CE symposium
held on April 5, 2006 at the American Nephrology
Nurses' Association (ANNA) Annual Meeting in Nashville, TN.
This symposium was approved
by ANNA. It was not part of the official ANNA
This activity provides 1.8 contact hours. The American Nephrology Nurses’ Association (ANNA) is accredited as a provider
of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910.
The educational objectives for this talk are presented on the conference page. To view the objectives, click
Posting Date: September 15, 2006
CE Credit Eligible
Through: September 15, 2008
CE Credit Hours/Completion Time: 1.8
Target Audiences: Nurses, nurse practitioners, and other healthcare professionals who treat and manage patients with CKD.
Method of participation: Listen to the talk, read the PubMed
abstracts linked to data slides and talk references, take the post-test, read
the linked abstracts in the post-test answer feedback material.
Andrea Easom, MA, MNSc, APN, BC, CNN, is a member of the Speakers Bureau for Watson Pharma, Inc.,
Abbott, Amgen, and Pfizer.No disclosed off-label use.
| SPEAKER DISCLOSURE STATEMENT:
This ANNA Satellite symposium was developed in conjunction with Fallon Medica and ANNA, and sponsored by a restricted educational grant from Watson Pharma, Inc.
The CE policy and disclosure statements of ANNA
are given in detail on the Symposium Home Page. The CE policy statements of HDCN are
| ANNA AND HDCN CE POLICY STATEMENTS: